Outset Medical announces $76.5 million Series C funding for innovative dialysis technology

Today we announced a $76.5 million Series C funding round, which brings us a step closer to making a significant and lasting impact on dialysis care. We are grateful to our new investor, T. Rowe Price Associates and our returning investors for their outstanding support.



Leave a Reply

Your email address will not be published. Required fields are marked *